Patent Yard Sign in
Canadian application, no grantCanada

Methods and compositions for treating periodontal disease

CA 2432504 A1 · Owner: Hartman, George D. · Inventors: Rodan, Sevgi B.; Rodan, Gideon A.; Hartman, George D.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides for a method for the treatment of alveolar bone loss due to periodontal disease in a subject in need of such treatment comprising administration of a therapeutically effective amount of an .alpha.v.beta.3 integrin receptor antagonist in combination with a therapeutically effective amount of a COX-2 inhibitor. Further the present , invention provides for pharmaceutical compositions useful in the methods of the present invention, as well as a method of manufacture of a medicament useful for treating the alveolar bone loss due to periodontal disease.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 28, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 28, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 28, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 28, 2001
GrantedNo grant recorded
Term endedDecember 28, 2021
Patent numberCA 2432504 A1
Classification (IPC)A61K31/50 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedDec 28, 2001Term endedDec 28, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.